An evolutionary "trap" has haunted crested and marbled newts for 25 million years: Leiden researchers have uncovered a mysterious DNA error that should not be able to arise—yet persists all the same.

A new study has developed a powerful computational method that can detect how genes interact with each other to influence ...

The Precision Fermentation Market is expanding rapidly as advancements in synthetic biology, growing consumer preference for sustainable and alternative proteins, and increasing investments in ...

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell ...

The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

Inside the station, every surface was wrapped with more ads—babies on turnstiles, on staircases, on banners overhead. “Think ...

North America currently leads the DNA Synthesis Market due to its mature biotech ecosystem, heavy investment in genomics, and ...

Genetic engineering is moving from the lab bench into clinics, farms, and even family planning decisions, promising to change ...

Mirum Pharmaceuticals ( MIRM 0.26%) is an excellent example of the latter category. This mid-cap stock has soared nearly 70% ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

A once-beleaguered gene-therapy stock just landed a major vote of confidence—and the timing seems anything but accidental.